RLMD
Relmada Therapeutics, Inc. Common Stock
$4.55
-7.02%
-0.34
Notify me if price changes either direction
Buy RLMD stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
324.9M
Enterprise value
341.0M
Trailing PE
-1.675207569914
Forward PE
-12.972222
PEG Ratio
0.028717844055669
Enterprise to EBITDA
-4.0469595033846
Price to book MRQ
16.385965
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Diluted EPS TTM
-1.78
Total Cash (MRQ)
13.9M
Current ratio (MRQ)
2.862
Operating Cash Flow (TTM)
-39990400
RLMD trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
